They're not bad; they're just prompted that way. Sysdig threat hunters documented what they say is the first-ever documented ...
The offices of Google are pictured in London on February 28, 2026. JUSTIN TALLIS/AFP via Getty Images Google released agents-cli on April 21, 2026, and it has shipped 13 updates in the 71 days since — ...
A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
The Callback is another bit of gadget nostalgia. It also has a very modern appeal. The Callback is another bit of gadget nostalgia. It also has a very modern appeal. is editor-at-large and Vergecast ...
What just happened? The company that gave the world the Commodore 64 and the Amiga is back with a flip phone. Commodore has unveiled the Callback 8020, a retro-styled handset for people who want to ...
Commodore is making a phone that isn't a full-on smartphone, nor is it a dumbphone. It straddles the line in a very obviously nostalgia-baiting fashion. Before we talk about the new Commodore Callback ...
Commodore, the iconic computer brand of the 1980s, is once again back for your attention—slapping its name on the hottest trend: digital detox. What it can't run are distracting apps that pull you ...
The next gadget to bear the storied Commodore branding will be a flip phone. The Commodore Callback 8020 takes advantage of reinvigorated interest in dumb phones. Although Commodore’s phone has ...
Commodore’s latest comeback hinges on a surprising idea: a premium phone designed to limit your screen time—without fully disconnecting you.
Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. Andy has reviewed hundreds of smartphones and tablets, ...
Formulas are powerful tools for performing calculations and analyzing data in Excel. In this beginner’s guide, you’ll learn how to use formulas (with or without help from the Copilot AI assistant) and ...
After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease showed remarkable signs of progress. All it took was a single dose of an experimental ...